Detalhe da pesquisa
1.
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.
Gynecol Oncol;
172: 121-129, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37030280
2.
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Gynecol Oncol;
177: 20-31, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37625235
3.
Uterine sarcoma - time is worth its weight in gold.
Pol J Pathol;
74(1): 59-62, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37306355
4.
ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016-2019).
J Cancer Educ;
37(4): 1239-1244, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33387267
5.
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol;
22(7): 1034-1046, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34143970
6.
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.
Gynecol Oncol;
162(3): 652-660, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34294416
7.
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.
Int J Gynecol Cancer;
30(6): 819-824, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32354792
8.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med;
375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27717299
9.
Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.
Support Care Cancer;
25(3): 795-800, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27771784
10.
Link between diet and chemotherapy related gastrointestinal side effects.
Contemp Oncol (Pozn);
21(2): 162-167, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28947887
11.
Dietary intake variability in the cycle of cytotoxic chemotherapy.
Support Care Cancer;
24(6): 2619-25, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26732766
12.
Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer.
Support Care Cancer;
23(4): 1015-23, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25270849
13.
Epithelial Ovarian Cancer-Varied Treatment Results.
Healthcare (Basel);
11(14)2023 Jul 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37510484
14.
High-Volume Hospitals' Ovarian Cancer Care-Less Individual Approach or Better Treatment Results?
Curr Oncol;
29(8): 5278-5294, 2022 07 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35892988
15.
Expression of selected molecular factors in two types of endometrial cancer.
Adv Clin Exp Med;
30(10): 1057-1064, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34510841
16.
The effect of endurance and endurance-strength training on body composition and cardiometabolic markers in abdominally obese women: a randomised trial.
Sci Rep;
11(1): 12339, 2021 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34117276
17.
Endurance Training Depletes Antioxidant System but Does Not Affect Endothelial Functions in Women with Abdominal Obesity: A Randomized Trial with a Comparison to Endurance-Strength Training.
J Clin Med;
10(8)2021 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33921520
18.
Genotyping of human papillomavirus DNA in Wielkopolska region.
Ginekol Pol;
2021 Sep 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34541643
19.
The Effect of Endurance and Endurance-Strength Training on Bone Mineral Density and Content in Abdominally Obese Postmenopausal Women: A Randomized Trial.
Healthcare (Basel);
9(8)2021 Aug 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34442211
20.
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer.
Cancers (Basel);
13(4)2021 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33670479